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Correction {#Sec1}
==========

Following publication of the original article \[[@CR1]\], the authors reported errors on their article.

In Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"} of this manuscript, the costs presented in the "hospital episodes", "total cost to the health care system" and "average health care cost per person" columns were incorrect. Consequently, the numbers in the "Ratios" and "standard errors" columns related to the Hospital Episodes section of Table [5](#Tab5){ref-type="table"} were incorrect. The corrected Tables are shown below.Table 3Total cost of cancer during the first 12-months post-diagnosis by cancer type^1^COST TO THE AUSTRALIAN HEALTHCARE SYSTEM (AUD)Patient co-payment^5^ (AUD)N^2^Hospital episodes^3^ED presentationsMBS rebate^4^PBS rebateTotal cost to the healthcare systemAverage healthcare cost per person (SD)TotalAverage per person (SD)All cancers combined123,9003,824,163,40088,103,100263,243,600631,804,3004,807,314,40038,800 (42,900)127,673,7001000 (2000)Prostate cancer20,700374,172,6006,416,20036,828, 60038,650,600456,068,00022,000 (18,700)16,324,000800 (1200)Breast cancer15,400377,396,2006,744,70036,690, 600170,956,200591,787,70038,300 (31,300)21,040, 9001400 (1500)Colorectal cancer14,800643,503,40011,849,40030,563,00071,878,900757,794,70051,300 (39,800)16,979,5001100 (1800)Blood and lymphatic system13,300616,132,00013,286,60040,503,100176,947,100846,868,70063,600 (73,600)24,655,4001900 (4100)Melanoma of the skin12,30070,844,8001,575,70023,174,80012,506,700108,102,0008800 (13,400)4,945,100400 (500)Tracheal, bronchus and lung cancer11,100434,675,60015,618,40024,164,60045,331,000519,789,70046,800 (35,700)10,168,700900 (1700)Digestive organs10,100433,725,60012,668,10020,303,10031,119,600497,816,40049,400 (38,400)11,273,0001100 (2000)Cancers of the urinary tract6200202,334,9005,022,30010,703,00017,623,000235,683,20038,000 (32,600)4,816,000800 (1100)Gynaecological cancers5200159,616,7003,121,60010,475,00016,774,700189,988,00036,400 (32,700)5,171,8001000 (1600)Head and neck4000141,306,7002,478,20010,264,7009,019,700163,069,40040,500 (47,200)2,374,400600 (1200)Other or ill-defined cancers270076,240,9002,316,9004,295,3006,051,40088,904,50032,800 (31,500)2,239,700800 (1700)Thyroid and other endocrine glands260055,221,900799,4004,195,5003,631,30063,848,20024,600 (35,800)1,180,600500 (600)Eye, brain and CNS1900114,903,7003,113,9003,324,70017,342,800138,685,00071,800 (73,200)2,830,0001500 (2300)Mesothelioma, Kaposi Sarcoma, and soft tissue160069,741,2001,882,2003,245,2009,187,20084,055,90051,500 (47,800)2,080,1001300 (2200)Male genital organs, exc prostate90019,635,700678,9002,190,2002,267,40024,772,30026,800 (30,900)643,200700 (1200)Other skin cancer80015,355,100283,3001,749,4001,456,80018,844,60022,700 (30,200)541,900700 (1100)^1^Weighted results reported, and rounded to the nearest 100^2^Excluding broad cancer types with less than 500 individuals ('bone', and 'other thoracic and respiratory organs')^3^Admitted and non-admitted hospital episodes^4^MBS rebate, excluding items included as non-admitted hospital episodes^5^MBS and PBS patient co-paymentTable 4Total cost of cancer for the first 12-months post-diagnosis, by population groups^1^COST TO THE AUSTRALIAN HEALTHCARE SYSTEM (AUD)Patient co-payment^4^ (AUD)nHospital episodes^2^ED presentationsMBS rebate^3^PBS rebateTotal cost to the healthcare systemAverage healthcare cost per person (SD)TotalAverage per person (SD)Weighted total123,9003,824,163,40088,103,100263,243,600631,804,3004,807,314,40038,800 (42,900)127,673,7001000 (2000)Indigenous status Non-Indigenous Australian121,8003,749,654,00085,643,100259,009,200623,618,6004,717,924,90038,700 (42,800)126,913,1001000 (2000) Indigenous Australian210074,509,4002,459,9004,234,5008,185,70089,389,50042,700 (48,800)760,600400 (800)Rurality^5^ Metropolitan58,5001,738,821,80038,505,200125,884,200306,909,0002,210,120,30037,800 (39,900)65,570,6001100 (1900) Regional54,5001,721,146,80042,165,900116,837,100270,755,9002,150,905,70039,500 (43,800)52,061,4001000 (1900) Remote10,200352,165,6006,805,50019,718,20052,844,900431,534,20042,200 (53,800)9,831,6001000 (2500)IRSD^6^ Quintiles^5^ Q1 (Most disadvantaged)11,300387,822,90011,248,90021,232,90047,295,500467,600,30041,400 (44,100)9,226,300800 (1900) Q25700183,953,2003,180,50011,653,00028,801,500227,588,20039,800 (43,700)4,900,200900 (1800) Q319,900635,646,50014,727,50041,726,900102,484,100794,585,00039,900 (48,500)17,757,0001100 (1800) Q456,0001,715,299,90042,010,300128,352,200288,661,5002,174,323,90038,800 (42,000)59,401,2001100 (1800) Q5 (Least disadvantaged)30,200889,411,70016,309,30059,474,600163,267,3001,128,462,90037,300 (40,200)36,179,1001200 (2000)^1^Weighted results reported, and rounded to the nearest 100^2^Admitted and non-admitted hospital episodes^3^MBS rebate, excluding items included as non-admitted hospital episodes^4^MBS and PBS patient co-payment^5^Excluding individuals with missing postcodes^6^Index of Relative Socio-Economic DisadvantageTable 5Five generalized linear models of the cost of cancer for the first 12-months^1^Hospital episodes^2^ED presentationsMBS rebate^3^PBS rebatesPatient co-payment^4^RatioEstimate (SE)RatioEstimate (SE)RatioEstimate (SE)RatioEstimate (SE)RatioEstimate (SE)**Intercept**8.5519 **(0.0483) \*\*\***--**5.4363 (0.0728) \*\*\***--**5.7499 (0.0382) \*\*\***--**6.8536 (0.0721) \*\*\***--**4.7398 (0.0593) \*\*\*Age**1.010.0062 (0.0005) \*\*\*1.01**0.0103 (0.0008) \*\*\***1.00**−0.0021 (0.0004) \*\*\***0.99**−0.0109 (0.0008) \*\*\***1.00**0.0033 (0.0006) \*\*\*Female**0.88−0.1267 (0.0167) \*\*\*0.95**−0.0537 (0.0262) \***0.95**−0.0551 (0.0129) \*\*\***0.85**−0.1597 (0.0234) \*\*\***0.98**−0.0214 (0.0192)Indigenous Australians**1.020.0220 (0.0525)1.23**0.2095 (0.0752) \*\***0.92**−0.0888 (0.0402) \***0.82**−0.1928 (0.0735) \*\***0.39**−0.9315 (0.0619) \*\*\*Inner and outer regional area**1.040.0364 (0.0165) \*1.02**0.0196 (0.0275)**0.99**−0.0138 (0.0126)**1.04**0.0366 (0.0231)**0.94**−0.0571 (0.0189) \*\*Remote and very remote area**1.100.0947 (0.0268) \*\*\*1.03**0.0322 (0.0454)**0.90**−0.1092 (0.0207) \*\*\***1.10**0.0912 (0.0381) \***0.98**−0.0219 (0.0311)IRSD**^5^ Q21.020.0214 (0.0373)1.00**0.0004 (0.0626)**1.07**0.0675 (0.0289) \***1.05**0.0474 (0.0519)**1.00**−0.0026 (0.0432)IRSD**^5^ Q30.98−0.0232 (0.0279)1.01**0.0097 (0.0420)**1.08**0.0805 (0.0216) \*\*\***1.11**0.1053 (0.0389) \*\***1.00**−0.0020 (0.0324)IRSD**^5^ Q40.95−0.0510 (0.0250) \*0.98**−0.0215 (0.0368)**1.18**0.1642 (0.0193) \*\*\***1.17**0.1582 (0.0348) \*\*\***1.23**0.2033 (0.0289) \*\*\*IRSD**^5^ Q5 (least disadvantaged)0.93−0.0700 (0.0293) \*0.94**−0.0603 (0.0467)**1.00**0.0016 (0.0226)**1.19**0.1703 (0.0411) \*\*\***1.32**0.2746 (0.0338) \*\*\***\*p-value \< 0.05\*\*p-value \< 0.01\*\*\*p-value \< 0.001^1^Adjusted for age at diagnosis, sex, Indigenous status, rurality, IRSD quintiles, and broad cancer type^2^Admitted and non-admitted hospital episodes^3^MBS rebate, excluding items included as non-admitted hospital episodes^4^MBS and PBS co-payment is the cost to the patient^5^Index of Relative Socio-Economic Disadvantage

Subsequently, the following sentences needed to be corrected. Corrected content is shown in bold:

Abstract, Results, Discussion {#Sec2}
=============================

The total initial cost associated with newly diagnosed cancer for the healthcare system is **\$4.8** billion. Hospital episodes accounted for **80%** of the healthcare expenditure, followed by PBS (**13%**) and MBS (**5%**).

Results, subheading "Results of Cost of cancer during the first 12-months post-diagnosis by population group", 2nd paragraph: {#Sec3}
=============================================================================================================================

Indigenous Australians had significantly higher costs for ED presentations (23% higher), but significantly lower costs for MBS rebates (8% lower), PBS rebates (18% lower), and patient co-payments (61% lower) compared to non-Indigenous Australians. \[**The words "for hospital episodes (22%)" have been removed from the sentence**\].

The costs for hospital episodes were significantly higher in the first 12-months post-diagnosis with increasing remoteness, **4%** for people living in inner and outer regional areas, and **10%** higher for people living in remote and very remote areas compared to those living in metropolitan areas. \[**these percents were previously reported as 6% and 15% higher, respectively**\].

Compared to those living in the most disadvantaged areas (IRSD Q1), those in **quintiles 4--5** had decreasing costs associated with hospital episodes \[**quintiles 3--4 were previously reported**\].

The original article can be found online at 10.1186/s13561-018-0212-8
